| X23-10-ZQ001 |
Bcl-2 inhibitor Navitoclax, Purity ≥98%
|
|
| X23-10-ZQ002 |
Bcl-2 inhibitor ABT-737, Purity ≥98%
|
|
| X23-10-ZQ003 |
Bcl-2 inhibitor Obatoclax mesylate, Purity ≥98%
|
|
| X23-10-ZQ004 |
Bcl-2 inhibitor TW-37, Purity ≥98%
|
|
| X23-10-ZQ005 |
Bcl-2 inhibitor HA14-1, Purity ≥98%
|
|
| X23-10-ZQ007 |
Bcl-2 inhibitor Venetoclax, Purity ≥98%
|
|
| X23-10-ZQ008 |
Bcl-2 inhibitor BM-1074, Purity ≥98%
|
|
| X23-10-ZQ009 |
Bcl-2 inhibitor Sabutoclax, Purity ≥98%
|
|
| X23-10-ZQ010 |
Bcl-2 inhibitor WEHI-539 hydrochloride, Purity ≥98%
|
|
| X23-10-ZQ011 |
Bcl-2 inhibitor UMI-77, Purity ≥98%
|
|
| X23-10-ZQ012 |
Bcl-2 inhibitor AT-101, Purity ≥98%
|
|
| X23-10-ZQ013 |
Bcl-2 inhibitor A-1210477, Purity ≥98%
|
|
| X23-10-ZQ014 |
Bcl-2 antagonist BDA-366, Purity ≥98%
|
|
| X23-10-ZQ015 |
Bcl-2 antagonist BH3I-1, Purity ≥98%
|
|
| X23-10-ZQ016 |
Bcl-2 antagonist A-1155463, Purity ≥98%
|
|
| X23-10-ZQ017 |
Bcl-2 inhibitor A-1331852, Purity ≥98%
|
|
| X23-10-ZQ018 |
Bcl-2 inhibitor Apogossypolone, Purity ≥98%
|
|
| X23-10-ZQ019 |
Bcl-2 inhibitor MIM1, Purity ≥98%
|
|
| X23-10-ZQ020 |
Bcl-2 activator BAM7, Purity ≥98%
|
|
| X23-10-ZQ021 |
Bcl-2 inhibitor, Purity ≥98%
|
|
| X23-10-ZQ022 |
Bcl-2 inhibitor MCL-1/BCL-2-IN-4, Purity ≥98%
|
|
| X23-10-ZQ023 |
Bcl-2 inhibitor MCL-1/BCL-2-IN-3, Purity ≥98%
|
|
| X23-10-ZQ024 |
Bcl-2 inhibitor ML311, Purity ≥98%
|
|
| X23-10-ZQ025 |
Bcl-2 inhibitor S55746, Purity ≥98%
|
|
| X23-10-ZQ026 |
Bax-activator-106, Purity ≥98%
|
|
| X23-10-ZQ027 |
Bcl-2 inhibitor BM 957, Purity ≥98%
|
|
| X23-10-ZQ028 |
Bcl-2 inhibitor Marinopyrrole A, Purity ≥98%
|
|
| X23-10-ZQ029 |
Bcl-2 inhibitor AZD-4320, Purity ≥98%
|
|
| X23-10-ZQ030 |
Bcl-2 inhibitor A-385358, Purity ≥98%
|
|
| X23-10-ZQ031 |
Bcl-2 inhibitor AZD5991, Purity ≥98%
|
|
| X23-10-ZQ032 |
Bcl-2 modulator BTSA1, Purity ≥98%
|
|
| X23-10-ZQ033 |
Bcl-2 inhibitor WEHI539, Purity ≥98%
|
|
| X23-10-ZQ035 |
Bcl-2 inhibitor AT101 acetic acid, Purity ≥98%
|
|
| X23-10-ZQ036 |
Bcl-2 inhibitor (+)-Apogossypol, Purity ≥98%
|
|
| X23-10-ZQ037 |
Bcl-2 inhibitor (S)-Gossypol acetic acid, Purity ≥98%
|
|
| X23-10-ZQ039 |
Bax inhibitor peptide P5, Purity ≥98%
|
|
| X23-10-ZQ040 |
Bax channel blocker, Purity ≥98%
|
|
| X23-10-ZQ041 |
Bax inhibitor peptide V5, Purity ≥98%
|
|
| X23-10-ZQ042 |
Bax inhibitor peptide, Negative control, Purity ≥98%
|
|
| X23-10-ZQ043 |
Bcl-2 inhibitor Pyridoclax, Purity ≥98%
|
|
